These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Loss to follow-up in registries of rheumatic patients treated with biologics: a potential information bias in assessing pharmacovigilance and efficacy outcomes. Valido A; Silva-Dinis J; Cruz-Machado AR; Gonçalves MJ; Romão VC; Saavedra MJ; Fonseca JE Acta Reumatol Port; 2019; 44(4):281-287. PubMed ID: 32281966 [TBL] [Abstract][Full Text] [Related]
6. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Hyrich KL; Watson KD; Silman AJ; Symmons DP; Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046 [TBL] [Abstract][Full Text] [Related]
7. Some principles of the development of a clinical database/national register of selected inflammatory rheumatic diseases in the Czech Republic. Dostal C; Pavelka K; Zvárová J; Hanzlícek P; Olejárová M Int J Med Inform; 2006; 75(3-4):216-23. PubMed ID: 16169767 [TBL] [Abstract][Full Text] [Related]
8. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice. Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800 [TBL] [Abstract][Full Text] [Related]
12. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. Zink A; Thiele K; Huscher D; Listing J; Sieper J; Krause A; Gromnica-Ihle E; von Hinueber U; Wassenberg S; Genth E; Schneider M; J Rheumatol; 2006 Jan; 33(1):86-90. PubMed ID: 16395755 [TBL] [Abstract][Full Text] [Related]
13. DANBIO: a nationwide registry of biological therapies in Denmark. Hetland ML Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S205-7. PubMed ID: 16273809 [TBL] [Abstract][Full Text] [Related]
14. Biological therapies in the spondyloarthritides--the current state. Braun J; Sieper J Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239 [TBL] [Abstract][Full Text] [Related]
15. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. Hakala M; Pöllänen R; Nieminen P J Rheumatol; 1993 Oct; 20(10):1674-8. PubMed ID: 8295178 [TBL] [Abstract][Full Text] [Related]
16. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study. Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results. Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981 [TBL] [Abstract][Full Text] [Related]
18. A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland. Immonen K; Finne P; Grönhagen-Riska C; Pettersson T; Klaukka T; Kautiainen H; Hakala M Amyloid; 2011 Mar; 18(1):25-8. PubMed ID: 21284495 [TBL] [Abstract][Full Text] [Related]
19. Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in clinical practice: adverse events and other reasons for discontinuation of treatment. Levälampi T; Korpela M; Vuolteenaho K; Moilanen E Scand J Rheumatol; 2008; 37(1):6-12. PubMed ID: 18189188 [TBL] [Abstract][Full Text] [Related]